A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy

IgA Nephropathy Clinical Trial

Official title:

A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy: an Observational Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01538433
• Other study ID #: GGH201107
• Status: Completed
• Phase: N/A
• First received: February 19, 2012
• Last updated: August 17, 2015
• Start date: February 2012
• Est. completion date: December 2012

Study information

• Verified date: August 2013
• Source: Guangdong General Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: China: Ethics Committee
• Study type: Observational

Clinical Trial Summary

This is a survey of factors which affect a pathologically defined early or delayed diagnosis of IgA nephropathy in Guangdong General Hospital, Guangzhou, China. An early or delayed diagnosis of IgA nephropathy is pathologically defined using the recently published Oxford classification of IgA nephropathy. The factors to be surveyed include health examination including urine test, socioeconomic status of patients including education,etc.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 603
• Est. completion date: December 2012
• Est. primary completion date: December 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 14 Years to 80 Years

Eligibility

Inclusion Criteria:

• biopsy-proven IgA Nephropathy patients in Guangdong General Hospital, Guangzhou,China

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

• Glomerulonephritis, IGA
• IgA Nephropathy
• Kidney Diseases

Locations

Country	Name	City	State
China	Nephrology Department,Guangdong General Hospital	Guangzhou	Guangdong

Sponsors (1)

Lead Sponsor	Collaborator
Guangdong General Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Factors potentially affecting an early or delayed diagnosis of IgA Nephropathy		Before the biopsy	No
Secondary	Glomerular filtration rate(GFR) decline rate or reaching end-stage renal disease (ESRD) or doubling of serum creatinine		after the biopsy	No